Other Antiallergic Drugs

Other antiallergic drugs comprise diverse APIs that complement traditional antihistamines and mediator antagonists by targeting additional immunologic and inflammatory pathways. These agents include corticosteroid-sparing immunomodulators, mast cell stabilizers, anti-IgE therapies, JAK inhibitors, and drugs that suppress eosinophilic activation. They are used in conditions such as severe asthma, atopic dermatitis, allergic conjunctivitis, anaphylaxis prevention, and chronic urticaria unresponsive to standard therapy. Their mechanisms involve inhibiting cytokine release, stabilizing immune cells, reducing inflammatory infiltration, or modulating hypersensitivity responses. Available in topical, inhaled, oral, and injectable forms, these APIs provide advanced options for patients requiring stronger or more targeted allergy control.